Lipocine Stock (NASDAQ: LPCN) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 503.000 / 30.952K |
Day Range | - - - |
52 Wk Range | 2.310 - 5.950 |
Market Cap | $28.280M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 67 |
Short Interest | 2.54% |
Days to Cover | 11.01 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lipocine (NASDAQ: LPCN) through any online brokerage.
Other companies in Lipocine’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Onconova Therapeutics (NASDAQ:ONTX), Cocrystal Pharma (NASDAQ:COCP) and SCYNEXIS (NASDAQ:SCYX).
The latest price target for Lipocine (NASDAQ: LPCN) was reported by Cantor Fitzgerald on Thursday, July 27, 2023. The analyst firm set a price target for 33.00 expecting LPCN to rise to within 12 months (a possible 520.30% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Lipocine (NASDAQ: LPCN) is $5.32 last updated Today at March 28, 2024 at 7:35 AM EDT.
There are no upcoming dividends for Lipocine.
Lipocine’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Lipocine.
Lipocine is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.